Nomen: Levobupivacaine Base
Synonyma:1-Butyl-N-(2,6-dimethylphenyl)-piperidine-2-carboxamide;Chirocaine;Levobupivacaine;(2S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2α-carboxamide;2′,6′-Pipecoloxylidide, 1-butyl-, L-(-)-;1-Butyl-N-(2,6-dim;;(2S)-1-Butyl-N-(2,6-diMethylphenyl)-2-piperidinecarboxaMide
CAS:27262-47-1
MF:C18H28N2O
MW:288.43
punctum liquescens:136-137°C
Chemical Properties:Solidus albus
usus :Locus anestheticus usus pro anesthesia epidurali et intratheca.
Levobupivacaine medicamentum locale anestheticum est amino amide group. Est S-enantiomer of bupivacaine. Levobupivacaine hydrochloride vulgo venale ab Abbate sub nomine Chirocaine. Levobupivacaine indicatur pro anesthesia locali inter infiltration, nervus obstructionum, rentur, epidurale et anaesthesium intrathecum in adultis; et infiltration analgesia in liberis. Comparari bupivacaine, levobupivacaine minus vasodilationi coniungitur et actionis longiorem durationem habet. It is approximately 13 percent less potent (by molarity) than racemic bupivacaine and has a longer motor block onset time.
Clinical Use
Comparari bupivacaine, levobupivacaine minus vasodilationi coniungitur et actionis longiorem durationem habet. It is approximately 13 percent less potent (by molarity) than racemic bupivacaine and has a longer motor block onset time.
Indicia
Levobupivacaine indicatur pro anesthesia locali inter infiltration, nervus obstructionum, rentur, epidurale et anaesthesium intrathecum in adultis; et infiltration analgesia in liberis.
Contraindications
Levobupivacaine is contraindicated for IV regional anaesthesia (IVRA).
